Ciprofloxacin 400 MG/200ML-D5W - Base + 4 Option years - 765

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 is seeking to procure Ciprofloxacin 400 MG/200ML-D5W, an intravenous pharmaceutical infusion product, to support the Hines VA medical facility. This pre-solicitation notice announces the agency's intent to compete the requirement and alerts potential vendors to monitor for the full solicitation release. Interested contractors should ensure their products meet all FDA approvals and quality standards for intravenous pharmaceutical products, as compliance with applicable VA and federal procurement regulations will be mandatory. While the pre-solicitation notice does not specify detailed evaluation criteria at this stage, the full solicitation will include comprehensive specifications, evaluation criteria, pricing requirements, and submission instructions. The pre-solicitation notice was posted on April 14, 2026, with a due date of April 21, 2026, providing interested parties with one week to prepare for the anticipated solicitation release.

This contract opportunity is designated as a Total Small Business set-aside, meaning only small businesses are eligible to compete for the award. The solicitation, identified as 36C77026Q0112, is structured as a base contract plus four option years, providing a five-year overall performance period. The requirement specifies an estimated quantity of 765 units of Ciprofloxacin 400 MG/200ML-D5W across the entire contract period. No incumbent contractor or specific award value has been disclosed in the pre-solicitation notice. The pharmaceutical preparation manufacturing classification (NAICS 325412) and Drugs and Biologicals product service code (PSC 6505) identify the nature of the procurement within the federal contracting system.